Back to Search
JEFFERY WOO, M.D.
M.D.
Internal Medicine Physician
NPI: 1003037417IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301084065(MI)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
KANSAS CITY UNIVERSITY OF PHYSICIANS AND SURGEONS
Class of 2004
Research & Publications (20)
Modification of the bulk properties of the porous poly(lactide-co-glycolide) scaffold by irradiation with a cyclotron ion beam with high energy for its application in tissue engineering.
PMID 19584424·Biomed Mater·2009
7-preclinical
Obesity identified by discharge ICD-9 codes underestimates the true prevalence of obesity in hospitalized children.
PMID 18950792·J Pediatr·2009
8-other
A pilot study to examine the feasibility and acceptability of a community model for exercise prescription for patients with chronic disease.
PMID 19258627·Hong Kong Med J·2009
8-other
Structure-function studies on the active site of the coelenterazine-dependent luciferase from Renilla.
PMID 18359861·Protein Sci·2008
8-other
Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
PMID 18178070·Eur J Pharm Sci·2008
2-rct
The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
PMID 18253142·Clin Pharmacol Ther·2008
6-review
Mutational optimization of the coelenterazine-dependent luciferase from Renilla.
PMID 18826616·Plant Methods·2008
8-other
Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
PMID 18431038·J Pharmacol Sci·2008
6-review
Adverse event monitoring and multivitamin-multimineral dietary supplements.
PMID 17209219·Am J Clin Nutr·2007
6-review
Nasal absorption studies of granisetron in rats using a validated high-performance liquid chromatographic method with mass spectrometric detection.
PMID 17679558·Arch Pharm Res·2007
7-preclinical
A randomised controlled trial of Tai Chi and resistance exercise on bone health, muscle strength and balance in community-living elderly people.
PMID 17356003·Age Ageing·2007
4-observational
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
PMID 17328246·Arch Pharm Res·2007
4-observational
Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.
PMID 17079297·J Virol·2007
8-other
Quantitative determination of voglibose in pharmaceutical tablets using high-performance liquid chromatography-fluorescence detection with post-column derivatization and mass spectrometric detection.
PMID 16730153·J Pharm Biomed Anal·2006
8-other
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
PMID 16537392·Proc Natl Acad Sci U S A·2006
7-preclinical
Minimization of aggregation of secreted bivalent anti-human T cell immunotoxin in Pichia pastoris bioreactor culture by optimizing culture conditions for protein secretion.
PMID 16107287·J Biotechnol·2006
8-other
Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
PMID 15588717·Biochem Pharmacol·2005
4-observational
FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
PMID 16253311·Thromb Res·2005
8-other
Structural basis of cellular redox regulation by human TRP14.
PMID 15355959·J Biol Chem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1900 WEALTHY ST SE, STE 150
GRAND RAPIDS, MI 49506 - Phone
- (616) 459-3158
Quick Facts
- NPI
- 1003037417
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile